SUPRIYA NAIR: Open Payments
NPI 1841328077 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 15 payments from 10 companies in 2025. Trend: 2023 $726 · 2024 $294 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $169 |
| Otsuka America Pharmaceutical, Inc. | 1 | $108 |
| Corium, LLC | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $39 |
| Alkermes, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Noven Therapeutics, LLC | 1 | $20 |
Products named: CAPLYTA, REXULTI, Azstarys, TRINTELLIX, LYBALVI, VRAYLAR, Auvelity, Jornay PM.
Industry payments across AZ — which companies pay providers there.
